Literature DB >> 26923567

Depressive Symptoms and Risk of Postoperative Delirium.

Patrick J Smith1, Deborah K Attix2, B Craig Weldon3, Terri G Monk3.   

Abstract

OBJECTIVE: Previous studies have shown that elevated depressive symptoms are associated with increased risk of postoperative delirium. However, to our knowledge no previous studies have examined whether different components of depression are differentially predictive of postoperative delirium.
METHODS: One thousand twenty patients were screened for postoperative delirium using the Confusion Assessment Method and through retrospective chart review. Patients underwent cognitive, psychosocial, and medical assessments preoperatively. Depression was assessed using the Geriatric Depression Scale-Short Form.
RESULTS: Thirty-eight patients developed delirium (3.7%). Using a factor structure previously validated among geriatric medical patients, the authors examined three components of depression as predictors of postoperative delirium: negative affect, cognitive distress, and behavioral inactivity. In multivariate analyses controlling for age, education, comorbidities, and cognitive function, the authors found that greater behavioral inactivity was associated with increased risk of delirium (OR: 1.95 [1.11, 3.42]), whereas negative affect (OR: 0.65 [0.31, 1.36]) and cognitive distress (OR: 0.95 [0.63, 1.43]) were not.
CONCLUSION: Different components of depression are differentially predictive of postoperative delirium among adults undergoing noncardiac surgery.
Copyright © 2016 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Delirium; behavioral inactivity; depression; negative affect

Mesh:

Year:  2016        PMID: 26923567      PMCID: PMC4801765          DOI: 10.1016/j.jagp.2015.12.004

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  27 in total

1.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

2.  Clarifying confusion: the confusion assessment method. A new method for detection of delirium.

Authors:  S K Inouye; C H van Dyck; C A Alessi; S Balkin; A P Siegal; R I Horwitz
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

3.  Depression and exercise in elderly men and women: findings from the Swedish national study on aging and care.

Authors:  Magnus Lindwall; Mikael Rennemark; Anders Halling; Johan Berglund; Peter Hassmén
Journal:  J Aging Phys Act       Date:  2007-01       Impact factor: 1.961

Review 4.  Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia.

Authors:  Richard De La Garza
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

5.  Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit.

Authors:  E Wesley Ely; Ayumi Shintani; Brenda Truman; Theodore Speroff; Sharon M Gordon; Frank E Harrell; Sharon K Inouye; Gordon R Bernard; Robert S Dittus
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

Review 6.  Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures.

Authors:  Martin Bendszus; Guido Stoll
Journal:  Lancet Neurol       Date:  2006-04       Impact factor: 44.182

Review 7.  Relationship of neurotransmitters to the symptoms of major depressive disorder.

Authors:  David J Nutt
Journal:  J Clin Psychiatry       Date:  2008       Impact factor: 4.384

8.  Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression.

Authors:  Patrick J Smith; James A Blumenthal; Michael A Babyak; Benson M Hoffman; P Murali Doraiswamy; Robert Waugh; Alan Hinderliter; Andrew Sherwood
Journal:  Psychosom Med       Date:  2007-07-18       Impact factor: 4.312

Review 9.  Discovering endophenotypes for major depression.

Authors:  Gregor Hasler; Wayne C Drevets; Husseini K Manji; Dennis S Charney
Journal:  Neuropsychopharmacology       Date:  2004-10       Impact factor: 7.853

10.  Exercise and pharmacotherapy in the treatment of major depressive disorder.

Authors:  James A Blumenthal; Michael A Babyak; P Murali Doraiswamy; Lana Watkins; Benson M Hoffman; Krista A Barbour; Steve Herman; W Edward Craighead; Alisha L Brosse; Robert Waugh; Alan Hinderliter; Andrew Sherwood
Journal:  Psychosom Med       Date:  2007-09-10       Impact factor: 4.312

View more
  5 in total

1.  Postoperative but not preoperative depression is associated with cognitive impairment after cardiac surgery: exploratory analysis of data from a randomized trial.

Authors:  Choy Lewis; Mehmet E Dokucu; Charles H Brown; Lauren Balmert; Nina Srdanovic; Ashwin Shaan Madhan; Sahej Singh Samra; John Csernansky; Jordan Grafman; Charles W Hogue
Journal:  BMC Anesthesiol       Date:  2022-05-23       Impact factor: 2.376

2.  Effects of Memantine in a Mouse Model of Postoperative Cognitive Dysfunction.

Authors:  Ahmad Almahozi; Mohamed Radhi; Suja Alzayer; Amer Kamal
Journal:  Behav Sci (Basel)       Date:  2019-03-06

3.  Preoperative anxiety predicted the incidence of postoperative delirium in patients undergoing total hip arthroplasty: a prospective cohort study.

Authors:  Jun Ma; Chuanyao Li; Wei Zhang; Ling Zhou; Shuhua Shu; Sheng Wang; Di Wang; Xiaoqing Chai
Journal:  BMC Anesthesiol       Date:  2021-02-12       Impact factor: 2.217

4.  ATPase Inhibitory Factor 1 Is Critical for Regulating Sevoflurane-Induced Microglial Inflammatory Responses and Caspase-3 Activation.

Authors:  Yaru Xu; Ge Gao; Xiaoru Sun; Qidong Liu; Cheng Li
Journal:  Front Cell Neurosci       Date:  2021-12-15       Impact factor: 5.505

5.  Patient-Reported Outcome Measures (PROM) as A Preoperative Assessment Tool.

Authors:  Sunghye Kim; Pamela W Duncan; Leanne Groban; Hannah Segal; Rica Moonyeen Abbott; Jeff D Williamson
Journal:  J Anesth Perioper Med       Date:  2017-11-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.